Biolidics

company

About

Biolidics is focused on the development of medical devices to improve cancer diagnostics and patient care.

  • Singapore,Central Region,Singapore
  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
S$8.66M
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2009
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Clearbridge BioMedics Pte Ltd
Also Known As
Clearbridge Biomedics

Biolidics is a medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
S$15.26M
Biolidics has raised a total of S$15.26M in funding over 2 rounds. Their latest funding was raised on Jun 28, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 28, 2018 Series Unknown S$6.60M Detail
Mar 13, 2013 Series B S$8.66M 6 Vertex Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
6
Biolidics is funded by 6 investors. Vertex Ventures and Dark Horse Investment are the most recent investors.
Investor Name Lead Investor Funding Round
Vertex Ventures Yes Series B
Dark Horse Investment Series B
BioVeda Capital Series B
NUS Technology Holdings Series B
Spring SEEDS Capital Series B
Vertex Ventures Southeast Asia & India Series B

Employee Profiles

Number of Employee Profiles
4
Biolidics has 4 current employee profiles, including Board member Joo Hock Chua
Board member
Executive
Executive
Executive

Acquisition

Biolidics has acquired 1 organizations. Their most recent acquisition was Biomedical Laboratory on Mar 30, 2020. They acquired Biomedical Laboratory for $2.60M.

Date Company Name
Industry Acquisition Type Price
Genetics acquisition $ 2.60M Detail